Vanda Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.04

-0.17 (-3.26%)

As of Sep 23, 10:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +206.5% upside

Low Target $11.33

Average Target $15.45

High Target $18.37

Current Price $5.04

Current
$5.04

Target
$15.45

$11.33 $15.45 avg $18.37

Scenario Analysis

Bear Case

$11.33

124.8%

Low target

Base Case

$15.45

+206.5%

Avg target

Bull Case

$18.37

+264.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$9.94

-49.3% from high

52-Week Low

$4.27

+18.0% from low

Target vs 52W High

$15.45

+55.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%